A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer
A phase 3 trial of Bevacizumab, Carboplatin, Paclitaxel / nab-paclitaxel in non-small-cell lung cancer and small-cell lung cancer, run by Prestige Biopharma Limited, active and no longer recruiting.
Overview
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients is a phase 3 interventional study registered as NCT03390686 by Prestige Biopharma Limited, with 650 participants enrolled, started 2019-11-15 and due to reach its primary completion in 2024-07-01. Interventions recorded: Bevacizumab, HD204, Carboplatin, Paclitaxel. Conditions listed: Lung Cancer, Non-small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer
Shares Bevacizumab, Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer.
- TrialAn Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung Cancer
Shares Paclitaxel / nab-paclitaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialIPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialPembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-287
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-s
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialVolrustomig Priming Regimens Exploratory Phase II Platform Study
Shares Paclitaxel / nab-paclitaxel, Carboplatin, Small-cell lung cancer, Non-small-cell lung cancer.